Elevance Health（ELV）2025年10-K年度报告「NYSE」（英文版）（147页）.pdf

1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM 10-K(Mark One)ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THESECURITIES EXCHANGE ACT OF 1934For the fiscal year ended December 31,2025 ORTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934

2、For the transition period from to Commission file number:001-16751 ELEVANCE HEALTH,INC.(Exact name of registrant as specified in its charter)Indiana 35-2145715(State or other jurisdiction of incorporation or organization)(I.R.S.Employer Identification Number)220 Virginia Avenue Indianapolis,Indiana

3、46204(Address of principal executive offices)(Zip Code)Registrants telephone number,including area code:(833)401-1577 Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading symbol(s)Name of each exchange on which registeredCommon Stock,Par Value$0.01ELVNew York Stock Ex

4、changeSecurities registered pursuant to Section 12(g)of the Act:NONEIndicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes x No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Sectio

5、n 15(d)of the Act.Yes No xIndicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has

6、 been subject to such filing requirements for the past 90 days.Yes x No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(232.405 of this chapter)during the preceding 12 months(or for